nivolumab,ipilimumab
bms
['melanoma']
 bright and early for day 2 in paris for #esmo22 we caught up with dirk schadendorf ( ) who discussed results from the immuned study to be presented later today! #esmo22 #melanoma #skcsm 
The Video Journal of Oncology is dedicated to providing trusted information to improve knowledge, understanding and awareness of cancer. Intended for HCPs only.